药品注册申请号:078970
申请类型:ANDA (仿制药申请)
申请人:LUPIN LTD
申请人全名:LUPIN LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 6.25MG No No AB 2013/09/11 2013/09/11 Prescription
002 ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 12.5MG No No AB 2013/09/11 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2022/09/02 SUPPL-16(补充) Approval Labeling STANDARD
2019/11/29 SUPPL-12(补充) Approval Labeling STANDARD
2019/11/29 SUPPL-11(补充) Approval Manufacturing (CMC) UNKNOWN
2019/11/29 SUPPL-10(补充) Approval Labeling STANDARD
2019/11/29 SUPPL-9(补充) Approval Labeling STANDARD
2019/11/29 SUPPL-7(补充) Approval Labeling STANDARD
2019/11/29 SUPPL-6(补充) Approval Labeling STANDARD
2019/11/29 SUPPL-5(补充) Approval Labeling STANDARD
2015/11/05 SUPPL-3(补充) Approval Labeling STANDARD
2015/03/19 SUPPL-2(补充) Approval Labeling STANDARD
2013/09/11 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:ZOLPIDEM TARTRATE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:6.25MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021774 002 NDA AMBIEN CR ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 6.25MG Prescription Yes No AB 2005/09/02 SANOFI AVENTIS US
078148 002 ANDA ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 6.25MG Discontinued No No AB 2011/04/14 ENDO OPERATIONS
090107 001 ANDA ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 6.25MG Prescription No No AB 2011/07/01 SANDOZ
200266 001 ANDA ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 6.25MG Prescription No No AB 2013/09/10 APOTEX
078970 001 ANDA ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 6.25MG Prescription No No AB 2013/09/11 LUPIN LTD
204170 001 ANDA ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 6.25MG Prescription No No AB 2017/01/24 SUN PHARM
213592 001 ANDA ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 6.25MG Discontinued No No AB 2020/06/04 BRECKENRIDGE
活性成分:ZOLPIDEM TARTRATE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:12.5MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021774 001 NDA AMBIEN CR ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 12.5MG Prescription Yes Yes AB 2005/09/02 SANOFI AVENTIS US
078148 001 ANDA ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 12.5MG Discontinued No No AB 2010/12/03 ENDO OPERATIONS
090107 002 ANDA ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 12.5MG Prescription No No AB 2011/07/01 SANDOZ
200266 002 ANDA ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 12.5MG Prescription No No AB 2013/09/10 APOTEX
078970 002 ANDA ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 12.5MG Prescription No No AB 2013/09/11 LUPIN LTD
204170 002 ANDA ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 12.5MG Prescription No No AB 2017/01/24 SUN PHARM
213592 002 ANDA ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL 12.5MG Discontinued No No AB 2020/06/04 BRECKENRIDGE
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database